Tang, Wei

Correction of a genetic disease in mouse via use of CRISPR-Cas9

Wu, Y., Liang, D., Wang, Y., Bai, M., Tang, W., Bao, S., Yan, Z., Li, D., & Li, J. (2013) · Cell stem cell

CRISPR and Genetic EngineeringAnimal Genetics and Reproduction

Cited by 614

Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases

Li, H., Zuo, J., & Tang, W. (2018) · Frontiers in Pharmacology

Phosphodiesterase function and regulationProtein Tyrosine Phosphatases

Cited by 580

Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients

Su, H.-X., Yao, S., Zhao, W.-F., Li, M.-J., Liu, J., Shang, W.-J., Xie, H., Ke, C.-Q., Hu, H.-C., Gao, M.-N., et al. (2020) · Acta Pharmacologica Sinica

SARS-CoV-2 and COVID-19 ResearchFlavonoids in Medical Research

Cited by 456

Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells

Wu, Y., Zhou, H., Fan, X., Zhang, Y., Zhang, M., Wang, Y., Xie, Z., Bai, M., Yin, Q., Liang, D., et al. (2015) · Cell Research

CRISPR and Genetic EngineeringAnimal Genetics and Reproduction

Cited by 247